Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Measurement of Dynamic Hyperinflation During the 6-Minute Walk Test Using a Mobile Device.

Meys R, Schiefer M, de Nijs SB, Bindels H, de Kruif MD.

Respir Care. 2019 Feb;64(2):182-188. doi: 10.4187/respcare.06307. Epub 2018 Dec 24.

PMID:
30584067
2.

Long term survival after admission for COPD exacerbation: A comparison with the general population.

van Hirtum PV, Sprooten RTM, van Noord JA, van Vliet M, de Kruif MD.

Respir Med. 2018 Apr;137:77-82. doi: 10.1016/j.rmed.2018.02.015. Epub 2018 Feb 24.

PMID:
29605217
3.

[Hepatopulmonary syndrome. A consideration in patients with liver disease accompanied by dyspnoea and hypoxaemia].

van Hirtum PV, Bootsma GP, de Man RA, van Deursen CTBM, Bonta PI, de Kruif MD.

Ned Tijdschr Geneeskd. 2017;161:D1387. Dutch.

PMID:
28589869
4.

Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.

Lin C, Majoor CJ, Roelofs JJ, de Kruif MD, Horlings HM, Borensztajn K, Spek CA.

BMC Cancer. 2017 Feb 7;17(1):113. doi: 10.1186/s12885-017-3081-3.

5.

Timing of broncho-alveolar lavage for galactomannan testing in hematological oncology patients.

de Kruif MD, Gerritsen MG, van Haren EH, Bel EH, Jonkers RE.

Clin Respir J. 2017 Jul;11(4):534-536. doi: 10.1111/crj.12380. Epub 2015 Oct 2. No abstract available.

PMID:
26364561
6.

Procalcitonin guided antibiotic therapy in patients presenting with fever in the emergency department.

Limper M, van der Does Y, Brandjes DP, De Kruif MD, Rood PP, van Gorp EC.

J Infect. 2014 Oct;69(4):410-2. doi: 10.1016/j.jinf.2014.04.009. Epub 2014 May 10. No abstract available.

PMID:
24820656
7.

Streptococcal lung abscesses from a dental focus following tocilizumab: a case report.

de Kruif MD, van Gorp EC, Bel EH, Gerlag DM, Kunst PW.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6):951-3. Epub 2012 Dec 17.

PMID:
23101463
8.

Microparticles expressing tissue factor are concurrently released with markers of inflammation and coagulation during human endotoxemia.

Woei-A-Jin FJ, De Kruif MD, Garcia Rodriguez P, Osanto S, Bertina RM.

J Thromb Haemost. 2012 Jun;10(6):1185-8. doi: 10.1111/j.1538-7836.2012.04733.x. No abstract available.

9.

Procalcitonin as a potent marker of bacterial infection in febrile Afro-Caribbean patients at the emergency department.

Limper M, de Kruif MD, Ajubi NE, van Zanten AP, Brandjes DP, Duits AJ, van Gorp EC.

Eur J Clin Microbiol Infect Dis. 2011 Jul;30(7):831-6. doi: 10.1007/s10096-010-1150-5. Epub 2011 May 19.

10.

One-year epidemiology of fever at the Emergency Department.

Limper M, Eeftinck Schattenkerk D, de Kruif MD, van Wissen M, Brandjes DP, Duits AJ, van Gorp EC.

Neth J Med. 2011 Mar;69(3):124-8.

11.

The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever.

Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC.

J Infect. 2010 Jun;60(6):409-16. doi: 10.1016/j.jinf.2010.03.016. Epub 2010 Mar 27. Review.

PMID:
20347867
12.

Prescription of physical activity is not sufficient to change sedentary behavior and improve glycemic control in type 2 diabetes patients.

Wisse W, Boer Rookhuizen M, de Kruif MD, van Rossum J, Jordans I, ten Cate H, van Loon LJ, Meesters EW.

Diabetes Res Clin Pract. 2010 May;88(2):e10-3. doi: 10.1016/j.diabres.2010.01.015.

PMID:
20138384
13.

Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.

de Kruif MD, Limper M, Gerritsen H, Spek CA, Brandjes DP, ten Cate H, Bossuyt PM, Reitsma PH, van Gorp EC.

Crit Care Med. 2010 Feb;38(2):457-63. doi: 10.1097/CCM.0b013e3181b9ec33.

PMID:
20083920
14.

PTX3 predicts severe disease in febrile patients at the emergency department.

de Kruif MD, Limper M, Sierhuis K, Wagenaar JF, Spek CA, Garlanda C, Cotena A, Mantovani A, ten Cate H, Reitsma PH, van Gorp EC.

J Infect. 2010 Feb;60(2):122-7. doi: 10.1016/j.jinf.2009.11.010. Epub 2009 Dec 2.

PMID:
19961874
15.

The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy.

Jong E, Louw S, Meijers JC, de Kruif MD, ten Cate H, Büller HR, Mulder JW, van Gorp EC.

AIDS Patient Care STDS. 2009 Dec;23(12):1001-7. doi: 10.1089/apc.2009.0173.

PMID:
19929230
16.

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus.

de Kruif MD, Limper M, Hansen HR, de Ruiter J, Spek CA, van Gorp EC, ten Berge IJ, Rowshani AT, ten Cate H, Meesters EW.

Ann Rheum Dis. 2009 Oct;68(10):1654. doi: 10.1136/ard.2009.109405. No abstract available.

PMID:
19748921
17.

In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.

de Vos AF, Pater JM, van den Pangaart PS, de Kruif MD, van 't Veer C, van der Poll T.

J Immunol. 2009 Jul 1;183(1):533-42. doi: 10.4049/jimmunol.0802189.

18.

Differential dose-dependent effects of prednisolone on shedding of endothelial adhesion molecules during human endotoxemia.

Lemaire LC, de Kruif MD, Giebelen IA, van Zoelen MA, van't Veer C, van der Poll T.

Immunol Lett. 2008 Dec 22;121(2):93-6. doi: 10.1016/j.imlet.2008.09.005. Epub 2008 Oct 18.

PMID:
18930765
19.

Differential gene expression changes in children with severe dengue virus infections.

de Kruif MD, Setiati TE, Mairuhu AT, Koraka P, Aberson HA, Spek CA, Osterhaus AD, Reitsma PH, Brandjes DP, Soemantri A, van Gorp EC.

PLoS Negl Trop Dis. 2008 Apr 9;2(4):e215. doi: 10.1371/journal.pntd.0000215.

20.

The influence of corticosteroids on the release of novel biomarkers in human endotoxemia.

de Kruif MD, Lemaire LC, Giebelen IA, Struck J, Morgenthaler NG, Papassotiriou J, Elliott PJ, van der Poll T.

Intensive Care Med. 2008 Mar;34(3):518-22. Epub 2007 Dec 14.

21.

Effects of prednisolone on the systemic release of mediators of cell-mediated cytotoxicity during human endotoxemia.

de Kruif MD, Lemaire LC, Giebelen IA, Groot AP, Pater JM, van den Pangaart PS, Elliott PJ, van der Poll T.

Shock. 2008 Apr;29(4):458-61.

PMID:
17909456
22.

Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia.

de Kruif MD, Lemaire LC, Giebelen IA, van Zoelen MA, Pater JM, van den Pangaart PS, Groot AP, de Vos AF, Elliott PJ, Meijers JC, Levi M, van der Poll T.

J Immunol. 2007 Feb 1;178(3):1845-51.

23.

What role do coagulation disorders play in the pathogenesis of leptospirosis?

Wagenaar JF, Goris MG, Sakundarno MS, Gasem MH, Mairuhu AT, de Kruif MD, Ten Cate H, Hartskeerl R, Brandjes DP, van Gorp EC.

Trop Med Int Health. 2007 Jan;12(1):111-22. Review.

24.

Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.

Keller TT, van der Sluijs KF, de Kruif MD, Gerdes VE, Meijers JC, Florquin S, van der Poll T, van Gorp EC, Brandjes DP, Büller HR, Levi M.

Circ Res. 2006 Nov 24;99(11):1261-9. Epub 2006 Oct 26.

PMID:
17068293
25.

Dobutamine does not influence inflammatory pathways during human endotoxemia.

Lemaire LC, de Kruif MD, Giebelen IA, Levi M, van der Poll T, Heesen M.

Crit Care Med. 2006 May;34(5):1365-71.

PMID:
16540959
26.

Is chronic HIV infection associated with venous thrombotic disease? A systematic review.

Klein SK, Slim EJ, de Kruif MD, Keller TT, ten Cate H, van Gorp EC, Brandjes DP.

Neth J Med. 2005 Apr;63(4):129-36. Review.

27.

Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.

de Kruif MD, van Gorp EC, Keller TT, Ossewaarde JM, ten Cate H.

Cardiovasc Res. 2005 Feb 1;65(2):317-27. Review.

PMID:
15639470
28.

Infections and endothelial cells.

Keller TT, Mairuhu AT, de Kruif MD, Klein SK, Gerdes VE, ten Cate H, Brandjes DP, Levi M, van Gorp EC.

Cardiovasc Res. 2003 Oct 15;60(1):40-8. Review.

PMID:
14522405

Supplemental Content

Loading ...
Support Center